Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display

European Journal of Immunology

Volumn 39, Issue 12, 2009, Pages 3498-3510

  Li, Jian ^a   Wang, Yadi ^b   Liang, Yunfei ^a   Ni, Bing ^a   Wan, Ying ^a   Liao, Zhiyong ^b   Chan, Kwok Hong ^c   Yuen, Kwok Yung ^c   Fu, Xiaolan ^a   Shang, Xiaoyun ^a   Wang, Shufeng ^a   Yi, Dong ^a   Guo, Botao ^a   Di, Biao ^d   Wang, Ming ^d   Che, Xiaoyan ^b   Wu, Yuzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Antigenic sites; Evolution analysis; HA; Immunodominant positions

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; YEAST CELL;

AMINO ACIDS; ANTIBODIES, MONOCLONAL; ANTIGENIC VARIATION; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; EPITOPE MAPPING; EPITOPES; EVOLUTION, MOLECULAR; FLOW CYTOMETRY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; YEASTS;

EID: 73249125589     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939532     Document Type: Article

References (30)

1. Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S. et al., Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998. 351: 472-477.
2. Chen, H., Smith, G. J., Li, K. S., Wang, J., Fan, X. H., Rayner, J. M., Vijaykrishna, D. et al., Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl. Acad. Sci. USA 2006. 103: 2845-2850.
3. Dung, N. T., Vinh, N. T., Vijaykrishna, D., Webster, R. G., Guan, Y., Malik Peiris, J. S. and Smith, G. J., Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg. Infect. Dis. 2008. 14: 632-636.
4. Smith, G. J., Vijaykrishna, D., Ellis, T. M., Dyrting, K. C., Leung, Y. H., Bahl, J., Wong, C. W. et al., Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. Emerg. Infect. Dis. 2009. 15: 402-407.
5. Bush, R. M., Bender, C. A., Subbarao, K., Cox, N. J. and Fitch, W. M., Predicting the evolution of human influenza A. Science 1999. 286: 1921-1925.
6. Ferguson, N. M., Galvani, A. P. and Bush, R. M., Ecological and immunological determinants of influenza evolution. Nature 2003. 422: 428-433.
7. Plotkin, J. B. and Dushoff, J., Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc. Natl. Acad. Sci. USA 2003. 100: 7152-7157.
8. Wiley, D. C., Wilson, I. A. and Skehel, J. J., Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981. 289: 373-378.
9. Lee, C. W., Senne, D. A. and Suarez, D. L., Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 2004. 78: 8372-8381.
10. Swayne, D. E. and Kapczynski, D.R., Vaccines, vaccination, and immunology for avian influenza viruses in poultry. In Swayne, D.E. (Ed.), Avian Influenza, Blackwell Publishing, Ames, IA, USA 2008, pp. 407-451.
11. Horimoto, T., Takada, A., Fujii, K., Goto, H., Hatta, M., Watanabe, S., Iwatsuki-Horimoto, K. et al., The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine 2006. 24: 3669-3676.
12. Wood, J. M., Major, D., Newman, R. W., Dunleavy, U., Nicolson, C., Robertson, J. S. and Schild, G. C., Preparation of vaccines against H5N1 influenza. Vaccine 2002. 20: S84-S87.
13. Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T.M., Rimmelzwaan, G. F., Osterhaus, A. D. and Fouchier, R. A., Mapping the antigenic and genetic evolution of influenza virus. Science 2004. 305: 371-376.
14. Jin, H., Zhou, H., Liu, H., Chan, W., Adhikary, L., Mahmood, K., Lee, M. S. and Kemble, G., Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 2005. 336: 113-119.
15. Lee, M. S. and Chen, J. S., Predicting antigenic variants of influenza A/H3N2 viruses. Emerg. Infect. Dis. 2004. 10: 1385-1390.
16. Lee, M. S., Chen, M. C., Liao, Y. C. and Hsiung, C. A., Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 2007. 25: 8133-8139.
17. Caton, A. J., Brownlee, G. G., Yewdell, J.W. and Gerhard, W., The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982. 31: 417-427.
18. Tsuchiya, E., Sugawara, K., Hongo, S., Matsuzaki, Y., Muraki, Y., Li, Z. N. and Nakamura, K., Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J. Gen. Virol. 2001. 82: 2475-2484.
19. Philpott, M., Easterday, B. C., and Hinshaw, V. S., Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity. J. Virol. 1989. 63: 3453-3458.
20. Kaverin, N. V., Rudneva, I. A., Govorkova, E. A., Timofeeva, T. A., Shilov, A. A., Kochergin-Nikitsky, K. S., Krylov, P. S. and Webster, R. G., Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 2007. 81: 12911-12917.
21. Boder, E. T. and Wittrup, K. D., Yeast surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol. 2000. 328: 430-444.
22. Mischo, A., Wadle, A., Watzig, K., Jager, D., Stockert, E., Santiago, D., Ritter, G. et al., Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immun. 2003. 3: 5.
23. Ellgaard, L. and Helenius, A., Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 2003. 4: 181-191.
24. Pepper, L. R., Cho, Y. K., Boder, E. T., and Shusta, E. V., A decade of yeast surface display technology: where are we now? Comb. Chem. High Throughput Screen. 2008. 11: 127-134.
25. Kaverin, N. V., Rudneva, I. A., Ilyushina, N. A., Varich, N. L., Lipatov, A. S., Smirnov, Y. A., Govorkova, E. A. et al., Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 2002. 83: 2497-2505.
26. Smith, D. J., Predictability and preparedness in influenza control. Science 2006. 312: 392-394.
27. Che, X. Y., Qiu, L. W., Pan, Y. X., Wen, K., Hao, W., Zhang, L. Y., Wang, Y. D. et al., Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J. Clin. Microbiol. 2004. 42: 2629-2635.
28. Xu, H., Di, B., Pan, Y. X., Qiu, L. W., Wang, Y. D., Hao, W., He,L. J. et al., Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections. J. Clin. Microbiol. 2006. 44: 2872-2878.
29. Liang, Y., Wan, Y., Qiu, L. W., Zhou, J., Ni, B., Guo, B., Zou, Q. et al., Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS. Clin. Chem. 2005. 51: 1382-1396.
30. Yamada, S., Suzuki, Y., Suzuki, T., Le, M. Q., Nidom, C. A., Sakai-Tagawa, Y., Muramoto, Y. et al., Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006. 444: 378-382.